Zhongshan Wanhan Pharmaceutical Co., Ltd (referred to as “the Company” hereinafter), founded in 2013 and affiliated to Bysunyen Group listed in Hong Kong, is a comprehensive national high-tech pharmaceutical enterprise dedicated to drug research and development, drug production, drug sales, and services. The Company has also been certificated as one of the first Innovative Benchmark Enterprises in Zhongshan City, Guangdong Provincial Engineering Technology Research Center, and Guangdong Provincial Enterprise Technology Center, is headquartered in South China TCM Center, Nanlang Town, Zhongshan City, Guangdong-Hong Kong-Macao Greater Bay Area, covering an area of 110 acres, and is divided into two strategic sections of active pharmaceutical ingredients and finished pharmaceutical products.
The Company has multiple subsidiaries including Zhongshan Wanyuan New Drug R&D Co., Ltd., Zhuhai Kangbaina Pharmaceutical Co., Ltd., and Zhuhai Aolixin Pharmaceutical Co., Ltd.
The leading personnel of the company’s R&D, production, and sales sectors all have years of executive background in listed companies and rich experience in the pharmaceutical industry, and are committed to using modern science and technology to provide consumers with safe and high-quality drugs and pharmaceutical services, enhance the quality of life of the public, and extend the life cycle.
Featuring business and products:
Development, technical services, and industrial applications of products and key technologies such as pharmatherapies for endocrine metabolism disorders, sensory disorders and viral infections, as well as, high value-added APIs and fine chemicals.
Manufacturing Park:API Plant
Technical personnel are richly experienced and capable of technical transformation. The API factory, covering an area of 50 acres, with a total construction area of 15000 square meters, is capable of production under high/low temperature, high pressure and hydrogenation conditions. The warehouse has complete supporting facilities and a total area of 4000 square meters, with qualifications for the use of controlled and highly toxic chemicals.
Manufacturing Park: Pharmaceutical Plant
The finished pharmaceutical product factory covers an area of 50 acres, with a construction area of 22000 square meters. It has the production capacity of oral solid preparations, pellicles, ointments, solutions, eye drops, and injections. The designed production capacities of oral solid preparations and eye drops are 500 million and 100 million doses per year, respectively
The Company is equipped with various analytical instruments, including high-performance liquid chromatographies, liquid-quality integrated analyzers, gas chromatographies, dissolution analyzers, etc., so as to meet the quality control requirements of solid preparations, sterile preparations, pellicles, and APIs.